Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery  by Karkouti, K. et al.
Karkouti et al Cardiopulmonary Support and PhysiologyHemodilution during cardiopulmonary bypass is an
independent risk factor for acute renal failure in adult
cardiac surgery
K. Karkouti, MD, MSca,b
W. S. Beattie, MD, PhDa
D. N. Wijeysundera, MDa,b
V. Rao, MD, PhDc
C. Chan, MDd
K. M. Dattilo, MDa
G. Djaiani, MDa
J. Ivanov, PhDc
J. KarskiaT. E. David, MDc
CS
PFrom the Department of Anesthesia, Uni-
versity Health Network, University of
Toronto,a Department of Health Policy,
Management, and Evaluation, University of
Toronto,b Department of Surgery, Division
of Cardiovascular Surgery, University
Health Network, University of Toronto,c
and Department of Medicine, Division of
Nephrology, University Health Network,
University of Toronto, Toronto, Ontario,
Canada.d
K. Karkouti and V. Rao are supported in
part by the Canadian Institutes of Health
Research; K. Karkouti is supported in part
by the Canadian Blood Services. No third-
party funding was used for this study.
Received for publication Jan 11, 2004; re-
visions received June 2, 2004; accepted for
publication June 22, 2004.
Address for reprints: Keyvan Karkouti,
MD, MSc, Department of Anesthesia, 3
Eaton N, Toronto General Hospital, Uni-
versity Health Network, 200 Elizabeth St,
Toronto, Ontario, Canada M5G 2C4 (E-
mail: keyvan.Karkouti@uhn.on.ca)
J Thorac Cardiovasc Surg 2005;129:
391-400
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.06.028Background: This observational study sought to determine whether the degree of
hemodilution during cardiopulmonary bypass is independently related to perioper-
ative acute renal failure necessitating dialysis support.
Methods: Data were prospectively collected on consecutive patients undergoing
cardiac operations with cardiopulmonary bypass from 1999 to 2003 at a tertiary care
hospital. The independent relationship was assessed between the degree of hemodi-
lution during cardiopulmonary bypass, as measured by nadir hematocrit concentra-
tion, and acute renal failure necessitating dialysis support. Multivariate logistic
regression was used to control for variables known to be associated with perioper-
ative renal failure and anemia.
Results: Of the 9080 patients included in the analysis, 1.5% (n  134) had acute
renal failure necessitating dialysis support. There was an independent, nonlinear
relationship between nadir hematocrit concentration during cardiopulmonary bypass
and acute renal failure necessitating dialysis support. Moderate hemodilution (nadir
hematocrit concentration, 21%-25%) was associated with the lowest risk of acute
renal failure necessitating dialysis support; the risk increased as nadir hematocrit
concentration deviated from this range in either direction (P  .005). Compared
with moderate hemodilution, the adjusted odds ratio for acute renal failure neces-
sitating dialysis support with severe hemodilution (nadir hematocrit concentration
21%) was 2.34 (95% confidence interval, 1.47-3.71), and for mild hemodilution
(nadir hematocrit concentration 25%) it was 1.88 (95% confidence interval,
1.02-3.46).
Conclusions: Given that there is an independent association between the degree of
hemodilution during cardiopulmonary bypass and perioperative acute renal failure
necessitating dialysis support, patient outcomes may be improved if the nadir
hematocrit concentration during cardiopulmonary bypass is kept within the identi-
fied optimal range. Randomized clinical trials, however, are needed to determine
whether this is a cause-effect relationship or simply an association.
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CSPThis study examined the relationship betweenthe degree of hemodilution during cardio-pulmonary bypass (CPB) in cardiac opera-tions and postoperative acute renal failure(ARF) necessitating dialysis support (ARF-D). Renal failure necessitating dialysis sup-
port is a devastating complication of cardiac surgery: it
occurs in 1% to 5% of patients and is strongly associated
with serious adverse events, including death.1-3
The current practice of CPB, which entails the addition
of 1.5 to 2 L or more of nonhematic fluids (crystalloid and
colloid fluids used to prime the CPB circuit) to the patient’s
blood volume, frequently results in marked hemodilution,
often to hematocrit concentrations less than 20%. This prac-
tice, which is in contrast to the early days of cardiac surgery,
when allogeneic blood was used as a prime to avoid he-
modilution, was adapted primarily to reduce the use of
blood products.4 Although this practice has now been ac-
cepted for more than 4 decades, there is a renewed debate
about the optimal degree of hemodilution during CPB.5,6
Recent studies have found a direct association between the
severity of hemodilution during CPB and perioperative
morbidity and mortality.6-9 More specifically, there is a
growing body of evidence linking low hematocrit concen-
trations during CPB with an increased risk of renal dysfunc-
tion.6,10,11 Earlier evidence, however, suggested that he-
modilution confers protection against renal injury.12,13
Although seemingly contradictory, these findings may
be congruent if the relationship between the degree of
hemodilution during CPB and post– cardiac operation
ARF is more U-shaped than linear. Hematocrit concen-
trations at the trough of the curve would confer the lowest
risk of renal dysfunction, with the risk increasing as the
hematocrit deviates from this optimal concentration in
either direction. The objective of this study was to de-
termine whether such an optimal hematocrit concentra-
tion exists by assessing the relationship between nadir
hematocrit concentration (nHct) during CPB and postop-
erative ARF-D while controlling for multiple periopera-
tive variables known to be related to perioperative renal
dysfunction and anemia. Such a finding would be impor-
tant for it would suggest a means of protecting the
kidneys against injury during cardiac operations.
Methods
After institutional ethics approval, data on consecutive adult (18
years) patients undergoing cardiac operation with CPB at the
Toronto General Hospital from June 1999 to June 2003 were
identified from a prospectively collected database, the details of
which have been previously described.14,15 A full-time research
nurse, who was blinded to the details of this study and to the
intraoperative hematocrit data, adjudicated all outcomes from pa-
tients’ medical records. Attending anesthesiologists, surgeons, and
perfusionists collected all preoperative and intraoperative data,
392 The Journal of Thoracic and Cardiovascular Surgery ● Febrwith the exception of blood-product transfusion data. A research
assistant obtained the transfusion data from the transfusion labo-
ratory’s database (Hemocare, Mediware Information Systems,
Melville, NY).
Study Setting and Clinical Practice
The Toronto General Hospital is a tertiary care teaching hospital
affiliated with the University of Toronto. A full range of adult
cardiac surgery procedures, including such complex procedures as
congenital heart disease repair and heart transplantation, is per-
formed at this hospital.
During the study period, patients were managed according to
standardized clinical protocols as described below.
Anesthetic management. Fast-track anesthesia with fentanyl
(10-20 g/kg), midazolam (0.1 mg/kg), pancuronium (0.15-0.20
mg/kg), isoflurane (0.5%-1.5%), and propofol (0.5-4 mg · kg1 ·
h1) was used. Patients were routinely monitored with pulmonary
artery catheters. Transesophageal echocardiography was routinely
used except for patients undergoing isolated aortocoronary bypass.
Epiaortic scanning was not routinely used. Antifibrinolytic
drugs—tranexamic acid (50-100 mg/kg) or aprotinin (6  106 U),
depending on bleeding risk—were used prophylactically in every
patient undergoing CPB.
CPB management. Anticoagulation was achieved with hepa-
rin to maintain an activated clotting time more than 480 seconds.
The CPB circuit was primed with 1.8 L of lactated Ringer’s
solution and 50 mL of 20% mannitol. Albumin (25%) and syn-
thetic colloids (Pentaspan; Bristol-Myers Squibb Canada Inc,
Montreal, Quebec, Canada) were added to the circuit as needed.
Management of CPB included systemic temperature drift to 34°C,
alpha-stat pH management, targeted mean perfusion pressure be-
tween 50 and 70 mm Hg, and pump flow rates of 2.0 to 2.4 L ·
min1 · m2. Myocardial protection was achieved with intermit-
tent antegrade and, occasionally, retrograde blood cardioplegia.
When necessary, deep hypothermic circulatory arrest (DHCA) was
achieved by cooling to 20°C with or without retrograde cerebral
perfusion. Furosemide was administered in response to persistent
oliguria or hyperkalemia.
During CPB, red blood cell concentrate (leukoreduced alloge-
neic or autologous) was transfused to maintain the hematocrit
concentration more than 17%. Pericardial blood was salvaged into
the cardiotomy suction reservoir and was reinfused via the CPB
circuit as long as patients were anticoagulated. After separation
from CPB, heparin was neutralized with protamine sulphate, 1 mg
per 100 U of heparin, to achieve an activated clotting time within
10% of baseline. After CPB, red blood cell concentrate was
transfused to maintain the hematocrit more than 21% to 24% in
stable patients and more than 27% in bleeding or unstable patients.
Dependent Variable
ARF was defined as a new requirement for postoperative dialysis.
Independent Variables
The primary variable of interest was nHct during CPB. Variables
that may be related to perioperative renal dysfunction1-3,16 or
anemia15,17,18 were considered for inclusion in the multivariate
analysis as confounding variables (Table 1).
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PTABLE 1. Bivariate relationship of independent variables with ARF-D
ARF-D No ARF-D P Value
Preoperative patient variables
Age, y (mean  SD) 64 14 62 12 .2
Sex
Male 90 (1.3%) 6708 .04
Female 44 (1.9%) 2238
Height, cm (mean  SD) 167 11 169 11 .07
Weight, kg (mean  SD) 74 17 79 16 .001
Hypertension
No 59 (1.4%) 4140 .6
Yes 75 (1.5%) 4806
Diabetes mellitus
No 81 (1.2%) 6693 .001
Yes 53 (2.3%) 2253
Peripheral vascular disease (history of aortoiliac,
femoropopliteal, or carotid disease or operation)
No 104 (1.3%) 7715 .004
Yes 30 (2.4%) 1231
Cerebrovascular disease (history of stroke or transient
ischemic attacks)
No 116 (1.4%) 8134 .07
Yes 18 (2.2%) 812
Hyperlipidemia (on treatment at time of operation)
No 62 (1.8%) 3402 .06
Yes 72 (1.3%) 5544
Smoker at time of operation
No 60 (1.9%) 3145 .02
Yes 74 (1.3%) 5801
Chronic obstructive pulmonary disease
No 126 (1.5%) 8013 .09
Yes 8 (0.8%) 933
Atrial fibrillation
No 111 (1.3%) 8391 .001
Yes 23 (4.0%) 555
New York Heart Association class
I or II 12 (0.5%) 2483 .001
III or IV 122 (1.8%) 6463
Left ventricular ejection fraction
40% 84 (1.2%) 7149 .001
40% 50 (2.7%) 1797
Unstable angina (within 30 d of operation)
No 73 (1.6%) 5140 .6
Yes 61 (1.4%) 3806
Recent myocardial infarction (within 30 d of operation)
No 109 (1.4%) 7519 .4
Yes 25 (1.7%) 1427
Recent cardiac catheterization (within 2 d of operation)
No 103 (1.3%) 8054 .001
Yes 31 (3.3%) 892
Congestive heart failure (at time of operation)
No 54 (0.8%) 7083 .001
Yes 80 (4.2%) 1863
Shock (at time of operation)
No 119 (1.3%) 8831 .001
Yes 15 (11.4%) 115
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ARF-D No ARF-D P Value
Endocarditis (at time of operation)
No 132 (1.5%) 8877 .4
Yes 2 (2.8%) 69
Intra-aortic balloon pump (inserted before operation)
No 121 (1.4%) 8726 .001
Yes 13 (5.6%) 220
Renal function (creatinine; mol/L; abnormal 100 in
women; 110 in men)
Normal 54 (0.7%) 7270 .001
Abnormal 80 (4.6%) 1676
Severe renal dysfunction (creatinine; mol/L; 200 in
women; 220 in men)
No 117 (1.3%) 8912 .001
Yes 17 (33.3%) 34
Hemoglobin concentration, g/dL (mean  SD) 12 2 13  1.5 .001
Preoperative operative variables
Urgency
Elective 88 (1.1%) 8252 .001
Urgent 46 (6.2%) 694
Repeat surgery
No 110 (1.3%) 8236 .001
Yes 24 (3.3%) 710
Procedure (for multivariate analysis, ACB and single valve
were combined)
ACB 52 (0.9%) 5835
Single valve 8 (0.9%) 895 .001
Other (complex) 74 (3.3%) 2216
Intraoperative variables
Lowest hematocrit during CPB, % (mean  SD) 21 4 23 4 .001
Highest blood glucose during CPB, mmol/L (mean  SD) 15.8 5.0 14.2 3.9 .001
Lowest mean arterial pressure during CPB, mm Hg (mean
 SD)
49  10 48 10 .1
CPB duration, min (mean  SD) 143 72 100 37 .001
Deep hypothermic circulatory arrest
No 124 (1.4%) 8653 .01
Yes 10 (3.3%) 293
RBC transfusion on the day of operation
No 26 (0.5%) 5056 .001
Yes 108 (2.7%) 3890
Excessive perioperative blood loss (5 U of RBC
transfused on the day of operation)
No 78 (0.9%) 8213 .001
Yes 56 (7.1%) 733
Post-CPB variables
Difficult wean from CPB (requirement for inotropes or
intra-aortic balloon pump)
No 42 (0.5%) 7763 .001
Yes 92 (7.2%) 1183
Re-exploration
No 90 (1.1%) 8434 .001
Yes 44 (7.9%) 512
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PStatistical Analysis
SAS version 8.2 (SAS Institute Inc, Cary, NC) was used for
statistical analyses. Database accuracy was measured by compar-
ing all outlying values with patients’ records and by reabstracting
the medical records of 200 randomly selected patients. Whenever
possible, missing values were completed from patients’ records;
otherwise, patients with missing categorical variable or nHct val-
ues were excluded. For continuous variables other than nHct,
missing values were imputed on the basis of the mean, according
to postoperative renal status, for the entire sample. Patients requir-
ing preoperative dialysis support were excluded from analysis.
The bivariate associations between the independent variables
and ARF-D were assessed by using appropriate tests (t test, Mann-
Whitney U test, 2 test, Fisher exact test, or Mantel-Haenszel test).
The bivariate associations between nHct and other independent
variables were assessed by the Pearson correlation test. Variables
that were associated (P  0.1) with both ARF-D and nHct were
included in the logistic regression analysis.
The mathematical relationships between the continuous inde-
pendent variables and the probability of ARF-D (logit transforma-
tion) were assessed with restricted cubic spline functions.19-21
Variables that were not linearly related were either mathematically
transformed or categorized for the logistic regression analysis.22 A
Pearson correlation matrix was used to identify collinear indepen-
dent variables.22
Two logistic regression models were constructed that con-
trolled for all identified confounders (for correlated variables, only
the most predictive was included in the multivariable analysis)
with ARF-D as the dependent variable. In model 1, nHct was
included in its quadratic from (nHct  sample mean of nHct)2 in
addition to its untransformed form to compensate for its nonlinear
relationship with ARF-D (as identified by the cubic spline function
analysis).22 In model 2, nHct was categorized into 3 hemodilution
groups: mild (nHct 25%), moderate (nHct 21%-25%), and se-
vere (nHct 21%). These cutoffs were defined by the 25th and
75th nHct percentiles. Each group was treated as a separate,
independent variable in the logistic regression analysis.22 In sen-
sitivity analyses, the robustness of the association between nHct
and ARF-D was assessed by repeating model 2’s regression anal-
ysis in 2 different subgroups: (1) excluding patients who had
severe baseline renal dysfunction (defined as creatinine concentra-
TABLE 1. Continued
Low-output syndrome (use of inotropes or mechanical
devices for 30 min to maintain blood pressure 90
mm Hg with a cardiac index 2.2 L · min1 · m2)
No
Yes
Adverse events (any of the following: arrhythmias requiring
treatment, myocardial infarction, pulmonary
complications, stroke, sepsis)
No
Yes
ARF-D, Acute respiratory failure necessitating dialysis; ACB, aortocoronation more than twice the upper limit of normal) and were therefore
The Journal of Thoraciat the highest risk for development of ARF-D and (2) including
only patients who underwent isolated aortocoronary bypass (by
providing a homogeneous patient population, this subgroup anal-
ysis removes many confounding issues, such as operative com-
plexity, DHCA, and antifibrinolytic use). All models were con-
structed by using backward stepwise variable selection with P 
.05 as the criterion for variable retention. The models’ fit was
assessed by the Hosmer-Lemeshow (goodness-of-fit) test (a larger
P value means better fit or reliability),23 and predictive accuracy
was assessed by the c-index (which is equivalent to the area under
the receiver operating characteristic [ROC] curve; an area of 0.5
indicates no predictive discrimination and an area of 1.0 indicates
perfect separation of patients with different outcomes).24
To explore the effects of risk adjustment on the association
between nHct and ARF-D, the distributions of the other indepen-
dent predictors of ARF-D (covariates in model 2) were obtained
for each of the hemodilution groups. The bootstrap technique25
was used to assess validity of model 2 as follows: 100 computer-
generated samples, each including 9000 patients, were derived
from the study population by random selection with replacement.
For each sample, model 2 was refitted, and the confidence intervals
(CIs) for the coefficients of the nHct categories were obtained.
Results
During the study period, 9215 patients underwent cardiac
operations with CPB. Fifty-seven patients were readmitted
for additional operations necessitating CPB; only data from
the first operation were used (ARF-D developed in none
after either operation). Forty-seven patients with missing
data and 88 patients with preexisting renal failure necessi-
tating dialysis were excluded, leaving a total of 9080 pa-
tients for analysis. Database accuracy was more than 95%.
The mortality rate was 1.7% (n  150); the ARF-D rate
was 1.5% (n  134). The unadjusted relationships between
ARF-D and the independent variables, including nHct as a
continuous variable, are shown in Table 1. Figure 1 shows
the spline function graph of the relationship between nHct
and ARF-D. On the basis of the shape of this relationship,
nHct was categorized as previously described into mild
ARF-D No ARF-D P Value
79 (0.9%) 8606 .001
55 (14.0%) 340
26 (0.4%) 6021 .001
108 (3.6%) 2925
ass; CPB, cardiopulmonary bypass; RBC, red blood cell concentrate.(25%), moderate (21%-25%), and severe (21%) he-
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ARF-D and nHct is presented in Figure 2.
The following baseline variables were associated with
ARF-D and nHct by bivariate analysis: sex, weight, diabe-
tes, peripheral vascular disease, cerebrovascular disease,
atrial fibrillation, left ventricular ejection fraction, recent
cardiac catheterization, shock, renal function, and hemoglo-
bin concentration. The following intraoperative and postop-
erative variables were also associated: urgency, procedure
type, highest blood glucose during CPB, DHCA, excessive
perioperative blood loss, difficult wean from CPB, re-
exploration, low output syndrome, and serious adverse
events. These variables, as well as age and CPB duration,
were included in the logistic regression analysis.
In models 1 and 2, nHct was independently associated
with ARF-D. In model 1, which included the quadratic form
of nHct, the risk of ARF-D was increased as nHct deviated
from the mean nHct of 23% (P  .005). The model was
reliable (Hosmer-Lemeshow test, P  .5) and discrimina-
tive (c-index, 0.94). When nHct was included as 3 categor-
ical variables, moderate hemodilution (nHct, 21%-25%)
was associated with the lowest risk of ARF-D. Compared
with moderate hemodilution, the odds ratio for ARF-D with
severe hemodilution (nHct 21%) was 2.34 (95% CI, 1.47-
3.71), and for mild hemodilution (nHct 25%) it was 1.88
(95% CI, 1.02-3.46). This model, which is presented in
Table 2, was also reliable (Hosmer-Lemeshow test, P  .4)
and discriminative (c-index, 0.94). The sensitivity analyses
(Table 3) showed the adjusted odds ratio for ARF-D to be
stable in the 2 patient subsets analyzed. The risk estimate for
the mild-hemodilution group, however, was not as robust as
Figure 1. Estimated spline transformation and 95% con
failure necessitating dialysis (ARF-D).the estimate for the severe-hemodilution group. Table 4
396 The Journal of Thoracic and Cardiovascular Surgery ● Febroutlines the risk profile of the hemodilution groups in terms
of the independent predictors of ARF-D (covariates in
model 2). In all 100 bootstrap samples, nHct remained in the
logistic regression model, with the 95% CI of the coeffi-
cients within 2% of those in model 2.
Discussion
This study found that the degree of hemodilution during
CPB, as measured by nHct, was independently related to the
risk of ARF-D. After adjustment for multiple potential
confounders, moderate hemodilution (nHct, 21%-25%) was
associated with the lowest risk of ARF-D, with the odds of
ARF-D 2.34 times (95% CI, 1.47-3.71) higher with severe
hemodilution (nHct 21%) and 1.88 times (95% CI, 1.02-
3.46) higher with mild hemodilution (nHct 25%).
These adjusted odds ratios were markedly different from
the unadjusted relationship between nHct and ARF-D (Fig-
ure 2). Adjustment for confounders reduced the risk of
severe hemodilution and increased the risk of mild hemodi-
lution relative to moderate hemodilution. This occurs be-
cause patients in the mild-hemodilution group have the most
favorable risk profile and those in the severe-hemodilution
group have the least favorable risk profile. The actual risk of
ARF-D that is attributable to nHct, therefore, becomes
evident only after these risk differences are accounted for by
multivariate analysis.
The observed association between the degree of hemodi-
lution during CPB and ARF-D is biologically plausible and
is supported by existing literature. According to postmortem
findings, the 2 most common etiologies for ARF after CPB
are acute tubular necrosis caused by inadequate oxygen
ce interval for nadir CPB hematocrit and acute renalfidendelivery and renal infarction caused, presumably, by micro-
uary 2005
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Pemboli.26,27 The degree of hemodilution during CPB affects
both renal oxygen delivery and renal embolic load.
Hemodilution and Renal Oxygen Delivery
Progressive hemodilution causes a proportional decrease in
the oxygen-carrying capacity of the blood. As blood be-
comes more dilute, however, it also becomes less viscous,
leading to increased blood flow in the macrocirculation and
microcirculation.28,29 This increased flow compensates for
the decreased oxygen-carrying capacity of blood, but only
to an as-yet-undefined “critical” hematocrit concentration
Figure 2. A, Unadjusted relationship between nadir CP
(ARF-D). B, Incidence of ARF-D in categories of nadirbeyond which further hemodilution results in reduced tissue
The Journal of Thoracioxygen delivery.30 In vitro studies have found that even
slight reductions in renal oxygen delivery can cause isch-
emic injury in certain highly susceptible areas of the kidney,
especially if the kidney’s energy requirements are in-
creased.31,32 Hematocrit concentrations below this critical level
would therefore place susceptible areas of the kidney at risk for
ischemic injury. Further aggravating this risk may be the
increased renal blood flow that occurs in response to hemodi-
lution, which may increase the energy requirements of the
kidney for tubular transport work by increasing renal perfusion
and the glomerular filtration rate.31,33 Yet another aggravating
matocrit and acute renal failure necessitating dialysis
hematocrit.B hefactor is the proportional reduction in plasma oncotic pressure
c and Cardiovascular Surgery ● Volume 129, Number 2 397
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that occurs with hemodilution. This results in the accumulation
of fluid in the interstitial space, which may ultimately lead to
capillary closure and reduced tissue oxygen delivery.4,28,30
Hemodilution and Renal Embolic Load
The conduct of CPB generates a large number of emboli of
various origins.34,35 The increase in renal blood flow asso-
ciated with hemodilution may increase the relative number
of emboli flowing to the kidneys, thereby increasing the risk
of renal infarction and ARF.
These pathophysiological mechanisms provide an expla-
nation for this study’s finding that severe hemodilution is
TABLE 2. Variables independently related to ARF-D: Resul
during CPB (nHCT) was included as 3 categorical variable
Variable Coe
Intercept
Preoperative variables
Diabetes mellitus (yes vs no)
Atrial fibrillation (yes vs no)
Renal function (abnormal vs normal)
Baseline hemoglobin (continuous; log trans) 
Urgency (urgent vs elective)
Procedure
Complex vs isolated
ACB or single valve
Intraoperative variables
nHCT during CPB
21% vs 21%–25%
25% vs 21%–25%
Post-CPB variables
CPB weaning problems (yes vs no)
Re-exploration (yes vs no)
Low-output syndrome (yes vs no)
Adverse events (yes vs no)
Hosmer-Lemeshow goodness-of-fit test  0.4; c-index  0.944. CI, Confid
TABLE 3. Sensitivity analyses*
Sample nHct
Odds
ratio 95% CI
Excluding patients with severe
preoperative renal
dysfunction
21% vs 21%–25% 2.2 1.4–3.6
25% vs 21%–25% 1.6 0.9–2.9
Including only patients who
underwent isolated ACB
21% vs 21%–25% 3.4 1.7–6.8
25% vs 21%–25% 1.3 0.4–4.1
nHct, Nadir hematocrit concentration; CI, confidence interval; ACB, aor-
tocoronary bypass.
*Both models were developed by using the same strategy as model 2
(refer to text).associated with a higher risk of ARF-D than is moderate
398 The Journal of Thoracic and Cardiovascular Surgery ● Febrhemodilution. This finding is also supported by other ob-
servational studies that have found a direct relationship
between the severity of hemodilution and increasing risk of
renal, hepatic, and central nervous system dysfunction, as
well as mortality.6-11
The other finding of this study, that mild hemodilution
may be associated with a higher risk of ARF-D than mod-
erate hemodilution, is equally plausible. Hemodilution dur-
ing CPB reduces red blood cell injury,29 an important cause
of renal dysfunction.27,36 Furthermore, hemodilution pre-
vents the deleterious trapping of red blood cells that occurs
in the renal microvasculature after renal ischemia.12,13
Through these mechanisms, as well as by improving micro-
circulatory blood flow as described previously, moderate
hemodilution may therefore confer more protection than
mild hemodilution against ischemic renal injury. In contrast
to this study, however, previous observational studies in
cardiac surgery did not find an increased risk of renal
dysfunction with mild compared with moderate hemodilu-
tion.6,11 This discrepancy may be due to differences in the
definition of ARF, sample size, study population, distribu-
tion of nHct, or statistical analyses. Of note, this study’s
estimated association between ARF-D and mild versus
moderate hemodilution was not as robust as that for severe
versus moderate hemodilution, as is evident by the 95% CIs in
both the primary (Table 2) and sensitivity (Table 3) analyses.
Several steps were taken in this study to ensure that the
f the logistic regression model in which nadir hematocrit
nt SE
Odds
ratio 95% CI
3.94
0.21 2.1 1.4–3.1
0.29 2.4 1.4–4.2
0.20 4.3 2.9–6.4
0.80 0.15 0.03–0.7
0.23 2.3 1.5–3.6
0.21 2.0 1.3–3.1
0.16 2.34 1.47–3.71
0.19 1.88 1.02–3.46
0.23 3.1 2.0–4.8
0.22 3.7 2.4–5.8
0.23 3.8 2.4–5.9
0.24 5.2 3.3–8.3
interval; ACB, aortocoronary bypass; CPB, cardiopulmonary bypass.ts o
s
fficie
1.14
0.74
0.88
1.46
1.9
0.83
0.70
0.35
0.14
1.13
1.32
1.33
1.66results were a valid estimate of the “true” relationship
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Pbetween nHct during CPB and renal dysfunction. First, a
clear and relevant measure of renal dysfunction—the need
for dialysis—was used, as opposed to a surrogate measure,
such as change in serum creatinine.37 Second, a prospec-
tively collected and accurate database was used. Third,
multiple confounders were identified and adjusted for, in-
cluding several measures of severity of illness, intraopera-
tive stability, surgical complexity, and perioperative com-
plications. Moreover, sensitivity analyses were performed
in different subgroups to further assess the role of several of
the more important potential confounders. Fourth, logistic
regression modeling was performed according to recom-
mended guidelines, including using an appropriately large
sample size (5 to 10 outcomes for each independent vari-
able) and ensuring that the continuous independent vari-
ables were classified in such a manner as to conform to the
linearity assumption of logistic regression.22 As a demon-
stration of the importance of the latter, when the nonlinear
relationship of nHct with ARF-D was ignored and it was
analyzed as a simple continuous variable, it was no longer
independently associated with ARF-D (results not shown).
Finally, this study included the entire cardiac surgery case-
mix of a single tertiary referral center in which patient
management was standardized. This increases the general-
izability of the results and at the same time ensures that the
observed association is not due to variations in clinical
practice.
Study Limitations
The results of our study must be interpreted cautiously for
several reasons. First, the database was created before this
study was conceived. Second, because it was an observa-
tional study, interpretation of the results should be limited to
associations between variables of interest; no causal infer-
ences should be drawn. Third, and most important, the
influence of unmeasured but potentially confounding vari-
ables on the observed association cannot be entirely ruled
out. For example, we did not collect, and therefore could not
TABLE 4. Risk profile of the hemodilution groups with res
Covariate Severe hemodi
Diabetes 30.2%
Atrial fibrillation 4.9%
Renal dysfunction 24.2%
Baseline hemoglobin, g/dL (mean  SD) 12.2 1.
Nonelective procedure 13.2%
Complex procedure 23.5%
CPB weaning problems 20.8%
Re-exploration 7.4%
Low-output syndrome 8.6%
Adverse events 36.5%
CPB, Cardiopulmonary bypass.control for, patients’ fluid balance. It is possible (but, given
The Journal of Thoracithe standardized practice of CPB and fluid management at
this institution, improbable) that patients with lower nHct
were overhydrated and that those with higher nHct were
underhydrated. Such a systematic difference in hydration
status would confound the observed relationship between
hemodilution during CPB and ARF-D. Other possible con-
founders include systematic differences in the type and the
dose of colloids and antifibrinolytics, both of which may
affect perioperative hemodilution and postoperative renal
function. Fourth, given that the observed association be-
tween mild and moderate hemodilution was not significant
in the subgroup analysis, it cannot be concluded that the risk
of ARF-D is higher with mild versus moderate hemodilu-
tion. Larger studies are required to provide a more accurate
estimate of this relationship.
Clinical Implications
Thus, despite the strengths of this study, we cannot recom-
mend that the practice of CPB be modified to maintain
patients’ hematocrit concentration within the “optimal”
range identified in this study. Before one can make such a
recommendation, which would entail increasing the cur-
rently accepted transfusion trigger during CPB, this finding
must first be confirmed by randomized controlled trials that
compare the renal effects of different hematocrit concentra-
tions during CPB. This is particularly important given that
some of the available options for maintaining higher hemat-
ocrit concentrations during CPB are not risk free. For ex-
ample, increasing the transfusion trigger during CPB may
reduce the risk of ARF, but it will concomitantly expose
patients to all the attendant risks of blood transfusion. Other
options, such as retrograde priming of the CPB circuit with
autologous blood, reducing the prime volume by using
smaller circuits, and ultrafiltration during CPB, may not be
appropriate in every case and may increase costs.
On the basis of the results of this study, as well as those
of other studies that have found an association between the
degree of hemodilution during CPB and postoperative organ
to covariates in model 2
Moderate hemodilution Mild hemodilution
25.3% 20.2%
6.4% 7.8%
19.0% 14.7%
13.5  1.3 14.6  1.1
6.6% 5.9%
23.6% 30.7%
12.3% 10.2%
5.7% 5.8%
3.4% 1.9%
33.2% 30.6%pect
lution
4dysfunction and mortality, it is our conclusion that random-
c and Cardiovascular Surgery ● Volume 129, Number 2 399
Cardiopulmonary Support and Physiology Karkouti et al
CSPized controlled trials comparing different degrees of he-
modilution are now mandated to determine whether there is
an “optimal” degree of hemodilution during CPB.
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